Sort
82,697 grants matching “vaccine development”
Construction/Regional Biocontainment Lab for Region VIII
$4,331,220Colorado State University-Fort Collins · UC6 · FY2005 · AI
IMPACTA PERU CLINICAL TRIALS UNIT
$4,328,745Javier R Lama · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2020 · AI
Advancement of Vaccines and Therapies for Henipaviruses
$4,326,275Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2020 · AI
Biodefense and Emerging Infectious Disease and Influenza Vaccine Studies
$4,323,375Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Regional Biocontainment Laboratory (RBL)
$4,319,910Duke University · UC6 · FY2005 · AI
IND-enabling program for a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
$4,314,989Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2024 · DA
Development of immunology and immunization strategies that induce broadly pro
$4,314,766Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2012 · AI
Influenza Vaccine Research and Development
$4,307,191Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
$4,303,129Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2023 · AI
Immunologic strategies to prevent congenital cytomegalovirus transmission and disease in rhesus monkeys
$4,302,307Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI
Northern New England Clinical and Translational Research Network
$4,299,999Clifford J Rosen · Mainehealth · U54 · FY2022 · GM
Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection
$4,299,740Mark M Davis · Stanford University · U19 · FY2015 · AI
PROJECT MANAGEMENT SUPPORT FOR COMMUNITY ENGAGEMENT ON TRANS-NIH THERAPEUTICS AND VACCINE TRIALS
$4,297,649Daniel Shingledecker · Deloitte Consulting, Llp · N02 · FY2021 · HL
Pandemic Influenza Translational Research; Novel Vaccine and Drug Therapy
$4,294,600Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine
$4,294,474Kimberly Wallace · Niaid Extramural Activities · Z01 · FY2007 · AI
Malaria Transmission Blocking Vaccine Discovery
$4,289,527Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Studies of Inherited Causes of Fungal Susceptability
$4,286,269Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Harvard University Center for AIDS Research
$4,278,137Bruce D Walker · Harvard Medical School · P30 · FY2014 · AI
Center for AIDS Research
$4,276,269David Mitchell Smith · University Of California, San Diego · P30 · FY2019 · AI
Arming the Immune System Against Pathogens
$4,276,251Harvard University (Sch Of Public Hlth) · P01 · FY2004 · AI
Influenza Vaccine Research and Development
$4,261,000Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Targeting Neutralizing Epitopes in the HIV Envelope
$4,260,986Susan W Barnett · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2009 · AI
Advancement of Vaccines and Therapies for Henipaviruses
$4,260,825Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2019 · AI
Broad neutralization of pandemic threat coronaviruses
$4,259,011Paul D Bieniasz · Rockefeller University · P01 · FY2023 · AI
Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine
$4,255,134Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI